The role of tyrosine-specific phosphorylation in v-fms-mediated transformation was examined by immunoblotting techniques together with a high-affinity antibody that is specific for phosphotyrosine. This antiphosphotyrosine antibody detected phosphorylated tyrosine residues on the gpl4Ov-fls molecule, but not gP180v-fs or gpl20v-fs, in v-fms-transformed cells. This antibody also identified a number of cellular proteins that were either newly phosphorylated on tyrosine residues or showed enhanced phosphorylation on tyrosine residues as a result of v-fms transformation. However, the substrates of the v-fms-induced tyrosine kinase activity were not the characterized pp6Ov-' substrates. The phosphorylation of some of these cellular proteins and of the gp140fPs molecule was found to correlate with the ability of v-fms/c-fms hybrids to transform cells. In addition, immunoblotting with the phosphotyrosine antibody allowed a comparison to be made of the substrates phosphorylated on tyrosine residues in various transformed cell lines. This study indicates that the pattern of tyrosine phosphorylation in v-fms-transformed cells is strikingly similar to that in v-sis-transformed cells.
gp140fPs molecule was found to correlate with the ability of v-fms/c-fms hybrids to transform cells. In addition, immunoblotting with the phosphotyrosine antibody allowed a comparison to be made of the substrates phosphorylated on tyrosine residues in various transformed cell lines. This study indicates that the pattern of tyrosine phosphorylation in v-fms-transformed cells is strikingly similar to that in v-sis-transformed cells.
Phosphorylation of proteins on tyrosine residues provides an ideal mechanism to elicit major changes in cellular growth and metabolism. Several growth factor receptors, such as those for platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin, and macrophage-specific colony-stimulating factor (CSF-1), have an associated tyrosine kinase activity as assayed in vitro (5, 37) . In each case, binding of the ligand stimulates the tyrosine kinase activity of the receptor. In this manner the tyrosine kinase activity may function to transmit an exogenous signal to multiple cellular targets by catalyzing phosphorylation on tyrosine residues and thereby activating growth-regulatory pathways. Interestingly, a number of retroviruses which induce continuous cellular proliferation encode transforming proteins with an associated tyrosine kinase activity (6, 32) . If the proliferation of cells is controlled by the transient activation of tyrosine kinase activity, then constitutive activation of this enzymatic activity may explain how these oncogene products cause the unlimited growth of cells in culture. v-fms, the transforming gene of the McDonough strain of feline sarcoma virus (SM-FeSV), is an example of such an oncogene with an associated tyrosine kinase activity (3, 22) . Furthermore, the v-fms cellular homolog (c-fms) is biochemically, structurally, and functionally related, if not identical, to the tyrosine kinase receptor for CSF-1 (7, 10, 33) .
The v-fms gene was formed by an in-frame insertion of c-fms sequences into gag sequences derived from feline leukemia virus (10, 12, 14) . The primary translation product is a fusion protein which is glycosylated cotranslationally in the endoplasmic reticulum to yield a 180-kilodalton (kDa) glycoprotein, gPl8Ov-fms (1, 2) . This molecule is proteolytically cleaved to form an amino-terminal gag fragment (p55gag) and a carboxy-terminal v-fms-encoded glycoprotein (gpl2Ov-fms) (4, 30, 36) . Some of the gpl2Ov-fms molecules are transported through the Golgi complex for further carbohy-* Corresponding author. drate processing before translocation to the plasma membrane, where they are detected as mature gpl4O-fms (1, 2) . The gpl4O-fms is oriented at the cell surface with its glycosylated amino-terminal domain outside the cell and its carboxyl-terminal domain in the cytoplasm, with the two domains separated by a single 25-amino-acid membranespanning region (26) . Cell surface expression of the mature gpl4oV-fms is essential for cellular transformation (24, 29) . The gpl4Ov-fms retains an intact extracellular ligand-binding domain, so that cells transformed by v-fms express glycoproteins at the cell surface which will bind CSF-1 (31, 33) . This observation raised the possibility that v-fms transformation might reflect retroviral transduction of a CSF-1 receptor gene into mesenchymal cells that synthesize the CSF-1 growth factor. Although fibroblasts susceptible to transformation by v-fms do produce CSF-1, v-fms-mediated transformation does not depend on an exogenous source of the growth factor, and neutralizing antibodies to CSF-1 do not affect the transformed phenotype (31) . In addition, expression of the c-fms gene in fibroblasts does not induce transformation (28) . These findings indicate that v-fms transformation is not simply a result of autocrine stimulation, but rather is mediated by a CSF-1-independent mechanism.
The cytoplasmic carboxy-terminal domain of both v-fms and c-fms shows amino acid sequence homology with pp6fisrc and other enzymes of the tyrosine kinase gene family (10, 14) . Genetic analysis demonstrates that the tyrosine kinase activity of pp6Ov-src and pp6E csrc and the state of the tyrosine phosphorylation of these proteins in vivo correlate with their ability to transform cells (8, 18, 20, 25) . However, such a correlation has not been established for the v-fms product. Immune complexes containing v-fms-coded molecules exhibit an associated tyrosine-specific protein kinase activity that phosphorylates all three v-fms glycoproteins in vitro (3, 29, 33) . In previous reports examining the phosphorylation state of gpl4Ov-fms and gpl2Ov-fms in vivo, Woolford et al. found trace amounts of phosphotyrosine (P-Tyr) in both proteins (40) , while Tamura et al. detected phosphory-176 lated tyrosine residues predominantly in the gpl40-fms molecule (35) . v-fms-transformed cells do not show an increase in total cellular P-Tyr, nor have cellular proteins with increases in P-Tyr content been identified in these cells by isotopic labeling techniques (3, 27, 35) . In addition, the correlation between the phosphorylation states in vitro and in vivo of the v-fms glycoproteins and the ability of v-fms to elicit the transformed phenotype have not been examined. Therefore, the role of the fms-associated tyrosine kinase activity in v-fms transformation is unclear.
To elucidate the role of tyrosine phosphorylation in v-fmsmediated transformation, we examined the phosphorylation of proteins on tyrosine residues in cells transfected with SM-FeSV-based vectors or infected with murine retroviral vectors encoding the v-fms gene or various v-fmslc-fms hybrid genes (7; Browning, unpublished results). To detect proteins phosphorylated on tyrosine residues in the v-fmstransformed cells, we used an antibody that specifically recognizes P-Tyr (19, 38) . These studies were conducted by immunoblot analysis of lysates prepared from the fmsproducing cell lines. This technique allows the identification of P-Tyr-containing proteins that might not be detected by isotopic labeling and two-dimensional gel analysis. Furthermore, this procedure is more advantageous than methods involving immunoprecipitation, in which the anti-P-Tyr antibody may not be able to recognize conformationally hidden P-Tyr residues. Results from our study indicate that the tyrosine phosphorylation in vivo of the gpl40fms and certain cellular proteins correlates with the transforming potential of v-fms.
MATERIALS AND METHODS Cell culture. NIH-3T3 and mink epithelial cell lines were maintained in Dulbecco modified Eagle medium supplemented with 10% (vol/vol) newborn bovine serum.
Antisera. The murine anti-fms monoclonal antibody was a gift from V. Rothwell (Fred Hutchinson Cancer Research Center, Seattle, Wash.), and the rat anti-v-fms monoclonal antibody was obtained from Oncogene Sciences. Antivinculin, antitalin, and anticalmodulin antibodies were provided by L. B. Chen (Dana-Farber Cancer Institute). Anti-p36 (lipocortin II) was obtained from B. Pepinsky (Biogen Research Corporation, Cambridge, Mass.). Murine anti-c-src monoclonal antibody (GD11) was a gift from S. Parsons (University of Virginia, Charlottesville).
Construction of vectors. Plasmids containing the SM-
FeSV-based vectors (SM-FeSV-v-fms, SM-FeSV-v/c-fms, and SM-FeSV-v/c/v-fms) were generated as previously described (7). The pLJ-fms-expressing vectors were constructed by inserting the gag-v-fms, gag-vlc-fms, and gagvlclv-fms sequences obtained from the SM-FeSV plasmids into the BamHI cloning site of the pLJ vector (21) .
Establishment offms cell lines. To generate mink epithelial lines expressing either the v-fms gene or hybrid v-fms/c-fms genes, an SM-FeSV vector containing the appropriate proviral genome was cotransfected with a pSV2neo plasmid into CCL64 cells by the calcium phosphate method (39) . The recipient cells were selected in medium containing G418 (34) , and drug-resistant lines were obtained. NIH-3T3 cell lines expressing either the v-fms gene or one of the fms hybrid genes were generated by using the pLJ vectors as described previously (25 at 25°C. All subsequent reactions were done at 25°C. Blots were incubated overnight with either anti-P-Tyr antibody or anti-fms monoclonal antibody diluted 1:7,000 in TBST. The primary antibody was removed, and the blots were washed three times for 5 min each in TBST. To detect antibody reactions, the blots were incubated for 45 to 90 min with either anti-rabbit immunoglobulin G (IgG) or anti-mouse IgG (alkaline phosphatase conjugated) diluted 1:2,000 in TBST, washed three times in TBST, and then placed in a buffer containing 100 mM Tris, pH 9.5, 100 mM NaCl, 5 mM MgCl2, 330 ,ug of 5-bromo-4-chloro-3-indolyl phosphate per ml, and 150 ,ug of Nitro Blue Tetrazolium per ml for 5 to 60 min. Enzymatic color development was stopped by rinsing the filters in deionized water.
Immunoprecipitation and protein kinase assays. For v-fms immunoprecipitation, 2 x 106 cells were washed twice with cold PBS and lysed in 1 ml PBS-TDS buffer (10 mM sodium phosphate, pH 7.2, 154 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS) containing 1 mM phenylmethylsulfonyl fluoride, aprotinin (0.15 U/ml), and 1 mM sodium vanadate at 4°C for 10 min. Insoluble material was removed by centrifugation at 4°C for 15 min at 10,000 x g. Cell lysates were normalized for protein content and immunoprecipitated overnight at 4°C with a rat monoclonal antibody which recognizes the 5' external domain of the v-fms proteins (Oncogene Science). Sepharose-linked protein A beads (Sigma Chemical Co.) coated with goat anti-rat IgG antibody were used to collect the antigen-antibody complexes. The immunoprecipitates were washed and analyzed for kinase activity as described previously (29) . The proteins were then separated electrophoretically on a 7.5% polyacrylamide-SDS gel, and the phosphoproteins were visualized by fluorography.
For c-src immunoprecipitations, 2 x 106 cells were washed once in methionine-free medium and incubated in 1.5 ml of methionine-free medium supplemented with 1 mCi of [35S]methionine per ml and 2 mM glutamine for 2 h at 37°C. Cells were lysed in PBS-TDS and normalized for protein content as described above. Two identical samples of each lysate were immunoprecipitated with anti-c-src monoclonal antibody for 1 h at 4°C. Immune complexes were collected on Sepharose-linked protein A beads. Immunoprecipitates were washed and either analyzed directly by SDS-PAGE or assayed for kinase activity. In vitro kinase assays VOL. 8, 1988 with exogenously added, acid-denatured enolase were performed as described previously (25) .
RESULTS
Tyrosine phosphorylation of the gpl4O-fms molecule. To detect residues on the v-fms glycoproteins that are phosphorylated on tyrosine in vivo, immunoblot experiments were conducted with an affinity-purified anti-P-Tyr antibody which is specific for tyrosine residues. Mink epithelial cells transfected with SM-FeSV-v-fms were analyzed in these experiments. Cytoplasmic cell lysates were prepared, and the extracted proteins were separated by SDS-PAGE and transferred electrophoretically to nitrocellulose filters. First, to determine that the v-fms gene was being expressed in this cell line, the blot was probed with a monoclonal antibody specific for the v-fms glycoproteins. In this experiment the blot was cut so that half of the lane was probed with the anti-fms antibody ( Identical experiments with NIH-3T3 v-fms-expressing cells were performed and confirmed these results (data not shown). Therefore, our findings agree with those of Tamura et al., who used isotopic labeling techniques to demonstrate phosphorylation in vivo of the gpl4Ov-fms molecule on tyrosine residues (35) . However, our experiments did not detect phosphorylated tyrosine residues in vivo on the gpl2Ov-fms or the gPl8Ov-fms glycoprotein.
Transforming potential of v-fmslc-fms hybrid proteins correlates with tyrosine phosphorylation of gp140fms. To determine the role of tyrosine phosphorylation of the gp140Yms molecule infms-mediated transformation, cell lines expressing v-fmslc-fms hybrid proteins were generated. SM-FeSVbased vectors were obtained that contained chimeric feline v-fms and human c-fms genes ( Fig. 2A) . In the v/c-fms hybrid construct, the entire cytoplasmic domain of the v-fms protein was replaced with the corresponding coding sequence of the c-fms gene by using a common PvuII site located just 3' to the transmembrane region. In the v/c/v-fms hybrid construct, a PvuII-BglI fragment encoding the c-fms tyrosine kinase domain was used to replace the corresponding v-fms coding sequences. Therefore, the v/c/v-fms hybrid gene contains the v-fms-encoded carboxy terminus, while the v/c-fms construct contains the c-fms-encoded carboxy terminus. The difference between these two carboxy termini is that the 40 terminal amino acids of the c-fms gene product are replaced in the v-fms gene with 11 unrelated codons of unknown origin (7, 10) . NIH-3T3 and mink epithelial cell lines expressing the v-fmslc-fms hybrids were generated. Cell lines were studied which expressed the fms proteins at approximately equal levels as determined by immunoblot analysis with an anti-v-fms antibody.
The transforming potential of the v-fmslc-fms hybrid cell lines was determined by focus formation and soft-agar growth assays. NIH-3T3 and mink cell lines containing the v/c/v-fms construct appeared morphologically transformed and formed colonies in 0.3% agar as efficiently as v-fmsexpressing cell lines (Fig. 2B) . However, NIH-3T3 and mink cell lines expressing the v/c-fms hybrid gene appeared morphologically identical to control cells and did not form colonies in soft-agar assays (Fig. 2B) . The v/c/v-fms hybrid gene construct did induce focus formation on a monolayer of NIH-3T3 cells, while the v/c-fms hybrid gene plasmid did not (Fig. 2B) . Based on these observations, the v/c-fms gene appeared to be nontransforming while the v/c/v-fms gene had a transforming potential equivalent to that of the v-fms gene in the transformation parameters assayed, suggesting that there are mutations in the extreme carboxy terminus of the v-fms gene which are necessary for the transformed phenotype.
To determine whether there was a correlation between transformation potential and phosphorylation of the gp140Ims molecule on tyrosine residues, cell lysates were prepared from the mink and NIH-3T3 cell lines expressing the v-fms, v/c-fms, and v/c/v-fms gene products and analyzed by immunoblot analysis with the anti-P-Tyr antibody. A distinct 140-kDa band was detected by the anti-P-Tyr antibody in the v/c/v-fms lines (Fig. 3A and B, lanes 3) which migrated identically to the 140-kDa band recognized in the v-fms lines (Fig. 3A and B, lanes 4) . However, no proteins of the same mobility as gpl4Ov-fms were recognized by the anti-P-Tyr antibody in either the control (Fig. 3A, lane 1 vlc-fms NIH-3T3 (Fig. 3A , lane 2) cell lines. There was one protein in the 140-kDa range of the control and vlc-fms mink cell lines (Fig. 3B, lanes 1 and 2) , but the migration of this protein was not identical to that of gpl40-fms. These findings were confirmed by immunoprecipitating the v-fis proteins from these cell lines and then probing the immunoprecipitates with anti-P-Tyr antibody (data not shown). Protein kinase assays were then performed in vitro to determine whether the v/c-fms gene products had functional associated tyrosine kinase activity. No significant difference was detected in the ability of the hybrid proteins to be phosphorylated in vitro when cell lines expressing v/c-fms (Fig. 4, lanes 2 and 6) or vlc/v-fms (Fig. 4, lanes 3 and 7) glycoproteins were assayed. The fms proteins were phosphorylated on tyrosine residues, as determined by phosphoamino acid analysis (data not shown). The v/c-fms molecules were slightly larger than the v/c/v-fms or v-fms proteins, reflecting the presence of additional amino acids in the c-fms carboxyl terminus. This analysis indicates that phosphorylation of the gp140fms protein on tyrosine residues in vivo as detected by the anti-P-Tyr antibody, rather than tyrosine phosphorylation of the fms molecules as observed in vitro, correlates with the transformation potential of the gene.
Changes in protein tyrosine phosphorylation in fms-transformed cells. To elucidate the role of oncogene-associated tyrosine kinase activities in mediating transformation, it is important to identify their cellular substrates in inltact cells. To date, no substrates for the v-fms oncogene have been detected. To address this question, we examined the v-fms and the v-fms/c-fms hybrid NIH-3T3 and mink cell lines by immunoblot analysis with the anti-P-Tyr antibody. While the anti-P-Tyr antibody did recognize some bands in both NIH-3T3 and mink control cells, we identified distinct proteins that either were newly phosphorylated on tyrosine residues or showed enhanced phosphorylation on tyrosine residues as a result of fms transformation (Fig. 3A, B, and C) . In the NIH-3T3 v-fms cell line, changes in the P-Tyr content of proteins, as detected by the anti-P-Tyr antibody, were observed at 200, 185, 140 (gpA4Vfm"), 110 to 115, 92, 75 to 85, 50, 41, and 30 kDa (Fig. 3A and C, lanes 4 versus lanes 1) . To determine whether any of the proteins recognized by the anti-P-Tyr antibody correlated with fms transformation ability, the staining pattern of the v-fms (Fig. 3A and C cell lines were assayed for tyrosine kinase activity in vitro as described previously (29) . Proteins were separated electrophoretically on 7.5% polyacrlyamide-SDS gels, and the phosphoproteins were detected by autoradiography (Fig. 3B, lanes 1 to  4, and Fig. 3C ). Thus, changes in the P-Tyr content of proteins which correlated with fms transformation in both the NIH-3T3 and mink cell lines were detected at 200, 140 (gp14Ofm'), 75 to 80, 50, 41, and 30 kDa. While some of the bands recognized by the anti-P-Tyr antibody were faint, we found their detection to be reproducible.
The specificity of the anti-P-Tyr antibody was confirmed by adding either P-Tyr or phosphoserine (P-Ser) to the primary antibody mixture. The addition of 40 mM P-Tyr to the prinary antibody mixture prevented detection of all bands by the anti-P-Tyr antibody in the NIH-3T3 v-fms cell line (Fig. 5, lane 1) , while the addition of P-Ser (Fig. 5, lane 2) at the same concentration had no effect. These results indicate that the anti-P-Tyr antibody did specifically recognize P-Tyr-containing proteins.
Substrates of v-fms-induced tyrosine kinase activity are not the characterized pp60sl'C substrates. In an attempt to determine the identity of the proteins detected by the anti-P-Tyr antibody in the v-fms-transformed cell lines, we performed immunoblot analysis with both the anti-P-Tyr antibody and antibodies to various cellular proteins. In these experiments the lysates from v-fms-transformed lines were first immunoprecipitated with an antibody which specifically recognized a known protein. The immunoprecipitated proteins were then separated by SDS-PAGE and transferred to a nitrocellulose filter before being probed with the anti-P-Tyr antibody. For these experiments, we obtained antibodies directed against proteins whose level of phosphorylation on tyrosine residues changes after v-src transformation (9, 11, 13, 16) . One example of this analysis is presented in Fig. 6A for anti-PTyr and anti-p36 (lipocortin II) antibodies. p36 immunoprecipitates from v-src-transformed NIH-3T3 cells (Fig. 6A , lane 2) were recognized by the anti-P-Tyr antibody, while p36 immunoprecipitates from control NIH-3T3 (Fig. 6A,  lane 1) , NIH-3T3 v-fms (Fig. 6A, lane 3) , and mink v-fms cell lines (Fig. 6A, lane 4) were not. For comparison, Fig. 6B shows total cell lysates of the same cell lines probed with anti-P-Tyr. Again, only in v-src-transformed NIH-3T3 cells was a 36-kDa protein recognized by the anti-P-Tyr antibody (Fig. 6B, lane 2) . In similar experiments, we determined that talin, p81 (ezrin), vinculin, calmodulin, and tensin were not detected by the anti-P-Tyr antibody in v-fms-transformed cells. However, the anti-P-Tyr antibody used for these studies did recognize vinculin, talin, and p81 (ezrin) in v-src-transformed NIH-3T3 cells (data not shown).
To determine whether v-fms transformation had an effect on the tyrosine kinase activity of pp6Oc-src, we examined the ability of pp60c-src from control and v-fms-transformed cells to phosphorylate enolase in vitro. In this experiment, NIH-3T3 cells and NIH-3T3 v-fms cells were labeled with [35S]methionine, and cell lysates were prepared, normalized for protein content, and immunoprecipitated with an anti-csrc monoclonal antibody. Immunoprecipitates were analyzed directly by SDS-PAGE (Fig. 7A) , or acid-denatured enolase was added and kinase assays were performed (Fig.  7B) . Immunoprecipitates from control and v-fnms-transformed NIH-3T3 cells contained equivalent amounts of pp60c-src (Fig. 7A) , and v-fms transformation did not alter the kinase activity of pp60c-src (Fig. 7B) . In addition, the state of tyrosine phosphorylation in pp6OC-src molecules in vivo did not change in v-fms-transformed cells, in that no phosphate was detected on Tyr-416 in pp6Oc-src molecules (H. Piwnica-Worms, unpublished observations).
Comparison of proteins recognized by anti-P-Tyr in various transformed cell lines. To determine whether the proteins recognized by the anti-P-Tyr antibody in v-fms-transformed cells were shared by other transformed cells, we compared the pattern of phosphorylated tyrosine bands in activated c-Ha-ras, v-src, v-fms, and polyomavirus middle T cell lines (Fig. 8A) . Compared with control NIH-3T3 cells (Fig. 8A,  lane 1) , only an additional band at -41 kDa was detected in activated c-Ha-ras-transformed cells (Fig. 8A, lane 5) , while in polyomavirus middle T-transformed cells, a group of bands was detected at 50 to 60 kDa (Fig. 8A, lane 3) . We determined that pp6Oc-rc and the polyomavirus middle T protein (56 kDa) were two of the proteins recognized by the anti-P-Tyr in the polyomavirus middle T-transformed cells (data not shown). The pattern of proteins detected in v-srctransformed cells (Fig. 8A, lane 4) was strikingly different from the v-fms (Fig. 8A, lane 2) and other transformed cell lines, with many bands being detected by the antibody. (Due to the high degree of staining in the v-src cell lysate, the development time of the blot presented in Fig. 8A was only 2 min versus 5 min for all other blots shown. In addition, all experirpents were done with excess antibody, so that substrate development time was the only experimental parameter which changed.)
Next, the pattern of phosphorylated tyrosine protein in v-fms- (Fig. 8B, lane 9 ) and v-sis- (Fig. 8B, lane 8) transformed cells was compared with that of NIH-3T3 cells treated with PDGF for various times (Fig. 8B, lanes 1 to 7) . The proteins which showed a change in tyrosine phosphorylation in response to PDGF stimulation were similar to those reported by Morla and Wang (23) . Changes in tyrosine phosphorylation were detected at >200, 180, 120, 100, 80 to 85, 75, 55 to 60, 45 to 43, and 41 kDa. Staining wa § strongest at S min after PDGF treatment and decreased during the 5-h period assayed. All phosphorylated tyrosine proteins induced by PDGF, except for the 43-kDa protein, appeared to be present in the v-sis-transformed cells but stained with different intensities. In the v-sis cell line, additional proteins were detected by the anti-P-Tyr antibody which were not detected in PDGF-treated cells (bands at 140, 130, 65, and 80 to 85 kDa). When comparing v-sis- (Fig. 8B, lane 8) and v-fms- (Fig. 8B, lane 9) by the anti-P-Tyr antibody above 100 kDa were different, but below 100 kDa virtually all of the bands recognized by the anti-P-Tyr antibody were common to the two cell lines, based on the results of one-dimensional gel analysis. This correlation also extended to the low-molecular-weight proteins (Fig. 8C, lanes 2 and 3) .
DISCUSSION
Using immunoblotting techniques together with a highaffinity antibody specific for P-Tyr, we made the following observations regarding the role of tyrosine-specific phosphorylation in v-fms-mediated transformation. The phosphorylation of the gp140Pms molecule correlated with the ability of v-fmslc-fms hybrids to transform cells. v-fms transformation resulted in the phosphorylation of a number of cellular proteins on tyrosine residues. Phosphorylation of some of these cellular proteins also correlated with the ability of v-fmslc-fins hybrids to transform cells.
By virtue of its associated tyrosine kinase activity, thefms oncogene is related to the largest group of oncogenes thus far identified (src, abl, yes, fps/fes, ros, fgr, erbB, trk, ret, and met) (5, 6, 32) . For several of these oncogenes, genetic analysis suggests that the tyrosine kinase activity is essential to the ability of the oncogenes to transform cells (18) .
Tyrosine kinase activity has also been demonstrated as a property of several growth factor receptors (PDGF receptor, insulin receptor, EGF receptor, and CSF-1 receptor) (18) . Binding of the appropriate ligand stimulates the tyrosine kinase activity of these receptors. Therefore, constitutive activity and/or altered substrate specificity of the tyrosine kinases may be an important component leading to transformation and/or growth factor-independent growth. Previous to this report, it has been difficult to determine the role of the fms-associated tyrosine kinase activity in v-fms-mediated transformation. However, the experimental techniques used in this report have suggested a role for tyrosine phosphorylation in v-fms-mediated transformation.
In contrast to previous reports in which phosphorylated tyrosine residues were detected in vivo on gpl40vf-rs and gpl20v-fs (35, 40) , we found that only the fully processed gpl4ovfsm was recognized by the anti-P-Tyr antibody in v-fms-transformed cell lines. It could be argued that the gpl20v-fms and the gP180v-fms do contain phosphorylated tyrosine residues that are not recognized by this antibody. However, even if this were the case, there was still a unique phosphorylated tyrosine site found only on the mature gpl40vf-fs. It is interesting that only fms molecules which are expressed on the cell surface were phosphorylated so that they could be detected by the anti-P-Tyr antibody. Genetic analysis of fms mutants indicates that cell surface expression of the glycoprotein is obligatory for the transformed phenotype (24, 29 Fig. 2 suggest that the percentage is sizable.
We have also shown a strong positive correlation between the transforming ability of v-fmslc-fms hybrids and the presence of P-Tyr in the gpl40 form of the fms molecule. In this analysis, two v-fms/c-fms hybrid genes were studied. The v/c/v-fms construct encoded a protein containing a v-fms external domain, transmembrane region, and carboxy terminus with a c-fms tyrosine kinase domain. Cells expressing v/c/v-fms proteins were morphologically transformed and formed foci in focus formation assays. The gpl4Ov/c/vfms, like the gp140v-fms, was phosphorylated on tyrosine residues in intact cells. Therefore, substitution of the c-fms tyrosine kinase domain into the v-fms gene did not affect the transforming potential of the v-fms protein ( Fig. 2 and 3 ) (P. Browning, unpublished results). Very different results were obtained for another v-fms/c-fms hybrid cell line. The v/cfms construct generated a fms protein containing the v-fms extracellular domain and transmembrane region while most of the cytoplasmic domain was encoded by the c-fms gene. In v/c-fms cell lines, the threefms forms were detected, and the v/c-fms glycoproteins had fully functional associated tyrosine kinase activity as assayed in vitro. However, evidence from the transformation parameters analyzed here and elsewhere (7) indicates that the v/c-fms hybrid is nontransforming. These data suggest that the c-fms cytoplasmic domain has markedly affected the transforming potential of the v-fms protein. The main structural difference between the v-fms and c-fms proteins is found in the cytoplasmic carboxy domain in that the terminal 40 amino acids of the c-fms protein are replaced by 11 different amino acids in the v-fms protein (7, 10) . As a result of retroviral transduction, this pattern of carboxy-terminal divergence and deletion also occurs in several other oncogenes and their respective proto-oncogenes, including c-and v-ros, c-and v-src, c-and v-fgr, c-and v-yes, and the EGF receptor and v-erbB (5, 17) . In all cases, includingfms, the carboxy termini of the cellular cognates contain tyrosine residues which may play important roles in regulating its tyrosine kinase activity. Experimentation has shown that mutation of Tyr-527 to Phe-527 in pp60c-src activates the molecule as a tyrosine kinase and as a transforming agent (8, 20, 25) . Data about the mutation of an equivalent carboxy-terminal tyrosine of c-fms (Tyr-969) to phenylalanine have shown that this change increases the transforming potential of the molecule but is not itself sufficient to induce transformation, indicating that other alterations are required (28) .
It is significant that the v/c-fms hybrid is an example of a fms product that was nontransforming, yet is expressed on the cell surface and has an associated tyrosine kinase activity, as observed in vitro. By immunoblot analysis, the gpl40v/c-f"s was not recognized by the anti-P-Tyr antibody, implying that the phosphorylated tyrosine residue found in gpl4v-fms and gpl40vfc/v-fms is not present in the v/c-fms molecule. Therefore, tyrosine phosphorylation of the gp 14O"ms in vivo is a better indicator of transformation ability thanfms-associated tyrosine kinase activity assayed in vitro.
The site(s) of tyrosine phosphorylation in the gpl40fms molecules in intact cells is unknown. However, the phosphorylated tyrosine residue recognized by the anti-P-Tyr antibody in gpl4ov-fms and gpl4Ov/c/v-fms was not Tyr-969, since this residue is not present in the truncated v-fms carboxy terminus. In addition, when Tyr-969 is present, as it was in gpl4O`vcffms, it is apparently not phosphorylated, since the gpl40v/c-fms was not detected by the anti-P-Tyr antibody. This is distinctly different from pp6Ocsrc, where the analogous residue, Tyr-527, is phosphorylated in vivo and could be detected by this anti-P-Tyr antibody (H. Piwnica-Worms, unpublished results).
Our findings indicate that as a result of v-fms transformation, there are distinct cellular proteins that either are newly phosphorylated on tyrosine residues or show enhanced phosphorylation on tyrosine residues. While the overall background staining in the control NIH-3T3 and mink cells was very different, the anti-P-Tyr antibody recognized a similar group of proteins whose phosphorylation state changed in these cell lines after v-fms transformation even though they were from different species (mouse and mink) and cellular origin (fibroblast and epithelial). The phosphorylation of many of the proteins correlated withfms-mediated transformation. Although some of the proteins recognized by the anti-P-Tyr antibody showed only slight increases in P-Tyr content, they may represent critical substrates. The increased P-Tyr content of proteins in v-fms-transformed cells suggests that they are substrates for the fms tyrosine kinase, but it is possible that they are phosphorylated by another protein tyrosine kinase activated as a result of v-fms transformation.
We also observed that the number of proteins which underwent new or increased phosphorylation on tyrosine residues in v-fms-transformed cell lines were few in comparison with v-src-transformed cells. By our analysis, many of the known v-src phosphorylated tyrosine substrates did not show changes in their phosphorylation state in v-fms cell lines. However, since no target for the v-src protein kinase activity has been described whose phosphorylation on tyrosine residues could account for the distortion of cellular proliferation that underlies transformation, the possibility remains that v-src and v-fms share critically important substrates. The data presented here do suggest that phosphorylation of gp140fms and a number of cellular proteins on tyrosine residues plays a role in transformation by the fms oncogene. The importance of these phosphorylations will be elucidated after identification of cellular substrates whose biochemical function is modulated by tyrosine phosphorylation.
From this study it appears that all transformed cells do not exhibit the same pattern of proteins phosphorylated on tyrosine residues, suggesting that these proteins are not simply phosphorylated on tyrosine residues as a result of constitutive cell proliferation. However, it is interesting that the pattern of tyrosine phosphorylation in v-fms-and v-sistransformed cells was very similar, indicating potentially common substrates in these two transformed cell lines. The v-sis oncogene is thought to mediate transformation, at least in part, by constitutively activating the PDGF receptor (15) .
The published sequence analysis indicates that the tyrosine kinase domain of the PDGF receptor and the c-and v-fms genes are highly homologous, with each containing an interrupted tyrosine kinase domain (41) . Perhaps this structural homology between the v-fms protein and the PDGF receptor results directly in the similar pattern of phosphorylated tyrosine substrates observed in v-fms-and v-sis-transformed cells. Alternatively, v-fms and v-sis may also increase tyrosine phosphorylation of proteins by mechanisms independent of PDGF growth-stimulatory pathways. Finally, the fact that each oncogene and activated receptor seemed to have a distinct pattern of P-Tyr-containing bands suggests that the immunoblotting techniques described here may be of use in measuring tyrosine kinase function in tissue samples as well. 183 VOL. 8, 1988 
